Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 109 results found. Search for [ biological products ]

Results 1 to 21 of 109
PTI
October 16, 2020
A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


BusinessToday.In
September 1, 2020
COVID-19 vaccine: The University of Oxford and AstraZeneca PLC has developed the first vaccine candidate to start the final round of testing of the coronavirus vaccine


BusinessToday.In
August 7, 2020
Coronavirus vaccine news update: Serum Institute of India would have exclusive rights for the supply of the Novavax COVID-19 vaccine in India


Kiran Mazumdar Shaw, Executive Chairperson, Biocon
New Delhi, August 5, 2020
Mining of huge data will enhance the probability of finding new drugs, making India the laboratory of the world


BusinessToday.In
July 22, 2020
Coronavirus (COVID-19) Vaccine News Latest Updates: Dr Cyrus Poonawalla, Chairman of the Poonawalla Group, says a just a few million doses of the potential COVID-19 vaccine will not be enough and the company intends to manufacture around 1 billion doses after getting all the necessary approvals


Nevin John
July 16, 2020
Ambani, during the annual general meeting on Wednesday, said the company will develop next-gen carbon capture and storage technologies and that it's evaluating novel catalytic and electrochemical transformations to use CO2 as a valuable feedstock


E Kumar Sharma
July 1, 2020
Bharat Biotech isn't committing a timeline, but considering the necessary processes, and if COVAXIN does not fail at any stage, the earliest it could hit the market is late 2021


BusinessToday.In
New Delhi, June 28, 2020
While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough


BusinessToday.In
New Delhi, June 26, 2020
Coronavirus vaccine update: Moderna has signed a deal with Catalent for large-scale manufacturing of its vaccine candidate. Catalent will provide vial filling and packaging capacity as well as additional workforce required for 24X7 manufacturing operations.


BusinessToday.In
June 25, 2020
The report by the German state of Baden-Wurttemberg states that Germany is an important area of operation for Iran, Pakistan, North Korea and Syria for securing relevant know-how through illegal procurement from the country


Chitranjan Kumar
New Delhi, June 19, 2020
On progress on treatment options for COVID-19, Cadila said it is working on a DNA vaccine to fight coronavirus, which is currently in the animal testing stage


PB Jayakumar
New Delhi, June 9, 2020
Whether India develops a Covid-19 vaccine/drug or not, Indian companies will be preferred partners for global pharma to make and distribute the life-saving drug globally


E Kumar Sharma
June 4, 2020
Swaminathan, who is arguably a go-to guru on issues related to farmers, believes that we can double farmer's income through appropriate marketing and by ensuring that they get a fair price


BusinessToday.In
New Delhi, June 1, 2020
Coronavirus vaccine news: In China, more than 2,000 people have been administered coronavirus vaccines developed by the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products


BusinessToday.In
New Delhi, May 31, 2020
Coronavirus vaccine update: Over 100 experimental COVID-19 vaccines are in various stages of development; from US-based Moderna Inc to China's CanSino Pharmaceuticals -- some of the world's biggest companies are in race to develop coronavirus vaccine


BusinessToday.In
May 17, 2020
Coronavirus vaccine update: World leaders and organisations except the United States have already pledged $8 billion to research, manufacture, and distribute a possible vaccine and treatment for COVID-19


PB Jayakumar
New Delhi, May 12, 2020
Pharmaceutical players will set up plants in major markets, go for more automation and focus on digital marketing


BusinessToday.In
New Delhi, May 11, 2020
Coronavirus crisis: Researchers across the globe are working on the vaccine for COVID-19, with some vaccine candidates at an advanced stage of clinical trial


BusinessToday.In
May 9, 2020
Globally, efforts are underway to develop a vaccine to treat Covid 19 which has stalled economic activity and led to death of over 2.77 lakh people across the world


PAGES 1 OF 6  12345